Open Journal Systems

Cover Image

Factors related to the escapement of reproductive age women from tetanus toxoid vaccination at the Sub – Divisional Medicalized Health Center Nkwen, Bamenda

Victorine M Ngachangong, Munting G Melanie, Emmanuel Ngohtu Tufon


The purpose of this study was to find out the factors related to the escapement of reproductive age women from tetanus toxoid vaccination at the Sub – Divisional Medicalized Health Center Nkwen Bamenda. A cross – sectional hospital based study was conducted in which 100 reproductive aged women (15 – 40 years) were randomly selected to participate. Demographic and clinical data were collected from participants and health personnel using a well – structured pre – tested questionnaire. From the results obtained, most of the women were within the age range of 26 – 30 years (41.1%) and were graduates (40.0%) that were employed (36.7%). Most of the reproductive age women had not taken any dose of the vaccine (54.5%) reasons being that they did not know the time the vaccine was given (80.0%), they were not aware (71.1%) and that they were scared of the side effects (61.0%). From the point of view of the health professionals, misconception about the vaccine (90.0%), poor socio – economic status (90.0%) and lack of awareness (80.0%) were the major reasons of the low tetanus toxoid vaccination coverage. In conclusion, majority of the reproductive age women are not vaccinated and notably, lack of awareness, fear of side effects and not knowing the time the vaccine is given were the main reasons for their escapement.


escapement, reproductive age women, tetanus, tetanus toxoid vaccine, sub – divisional Medicalized health center Nkwen, Bamenda

Full Text:



Pillitteri A, Pillitteri: Child health nursing: care of the child and family: Lippincott Williams & Wilkins; 1999.


Savage EJ, Nash S, McGuinness A, Crowcroft NS: Audit of tetanus prevention knowledge and practices in accident and emergency departments in England. Emergency Medicine Journal 2007, 24:417-421.

PMid:17513539 PMCid:PMC2658278

Allen C, Lueck C: Neurological disease, Chapter 22. Davidson's Principles and practice of medicines, 19th ed. Philedelphia: Churchill Livingstone 2002:1159-1168.

Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S: Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 2003, 21:3442-3445.

Elimination of Maternal and Neonatal Tetanus (2010). (accessed 10 September 2010).

Deming MS, Roungou J-B, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R: Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bulletin of the World Health Organization 2002, 80:696-703.

PMid:12378286 PMCid:PMC2567620

Elimination of Maternal and Neonatal tetanus by 2005 (online news). (accessed 9 March 2007).

Organization WH: Organisation mondiale de la santé. Relevé épidémiologique hebdomadaire. Weekly epidemiological record 2006, 81:273-284.

Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S: Tetanus toxoid immunization to reduce mortality from neonatal tetanus. International Journal of Epidemiology 2010, 39:i102-i109.

PMid:20348112 PMCid:PMC2845866

Antai D: Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population-based cross-sectional study. International Journal of Infectious Diseases 2012, 16:e136-e145.


Brown V, Oluwatosin O: Socio-demographic factors associated with childhood immunization uptake in Akinyele Local Government Area, Oyo State, Nigeria. African journal of medicine and medical sciences 2012, 41:161-167.


Dietz V, Milstien JB, Van Loon F, Cochi S, Bennett J: Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bulletin of the World Health Organization 1996, 74:619.

PMid:9060223 PMCid:PMC2486793

Nusrat N, Nousheen A, M F: Tetanus toxoid vaccination coverage amongst pregnant women at tertiary care hospital, Sindh Pakistan. . Gynaecology and Obstetrics 2010, 6:272-275.

Mohammad M: Determinants of the Utilization of the Tetanus Toxoid (TT) Vaccination Coverage in Bangladesh: Evidence from a Bangladesh Demographic Health Survey 2004. The Internet Journal of Health 2008, 8.

WHO. Global program for vaccine and immunization EPI, WHO, Geneva1998. Edited by.

WHO. Vaccine – preventable diseases monitoring system 2010 global estimates.2010 Available from TTV publication.doc (cited 10 September 2014).

Kidane T, Yigzaw A, Sahilemariam Y, Bulto T, Mengistu H, Belay T, Bisrat F, Benti D, Mbakuliyemo N, Olusegun B: National EPI coverage survey report in Ethiopia, 2006. Ethiopian Journal of Health Development 2009, 22:148-157.

Hasnain S, Sheikh N: Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan. Eastern Mediterranean Health Journal 2007, 13:1142-1152.


Mary M: Utilization of tetanus toxoid 1 and 2 immunization service among child bearing age women. 1989 34 (12).



  • There are currently no refbacks.